Working… Menu

A Study of LY3471851 in Participants With Eczema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04081350
Recruitment Status : Recruiting
First Posted : September 9, 2019
Last Update Posted : July 7, 2021
Nektar Therapeutics
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 16, 2022
Estimated Study Completion Date : August 16, 2022